Lysophosphatidic Acid and Sphingosine-1-Phosphate: A Concise Review of Biological Function and Applications for Tissue Engineering
- 1 December 2015
- journal article
- review article
- Published by SAGE Publications in Tissue Engineering Part B: Reviews
- Vol. 21 (6) , 531-542
Abstract
The presentation and controlled release of bioactive signals to direct cellular growth and differentiation represents a widely used strategy in tissue engineering. Historically, work in this field has primarily focused on the delivery of large cytokines and growth factors, which can be costly to manufacture and difficult to deliver in a sustained manner. There has been a marked increase over the past decade in the pursuit of lipid mediators due to their wide range of effects over multiple cell types, low cost, and ease of scale-up. Lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) are two bioactive lysophospholipids (LPLs) that have gained attention for use as pharmacological agents in tissue engineering applications. While these lipids can have similar effects on cellular response, they possess distinct chemical backbones, mechanisms of synthesis and degradation, and signaling pathways using a discrete set of G-protein-coupled receptors (GPCRs). LPA and S1P predominantly act extracellularly on their GPCRs and can directly regulate cell survival, differentiation, cytokine secretion, proliferation, and migration--each of the important functions that must be considered in regenerative medicine. In addition to these potent physiological functions, these LPLs play pivotal roles in a number of pathophysiological processes. To capitalize on the promise of these molecules in tissue engineering, these lipids have been incorporated into biomaterials for in vivo delivery. Here, we survey the effects of LPA and S1P on both cellular- and tissue-level phenotypes, with an eye toward regulating stem/progenitor cell growth and differentiation. In particular, we examine work that has translational applications for cell-based tissue engineering strategies in promoting cell survival, bone and cartilage engineering, and therapeutic angiogenesis.Keywords
This publication has 136 references indexed in Scilit:
- Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1‐phosphate signalling to regulate tumour metastasisEMBO Molecular Medicine, 2012
- Endogenous Bone Marrow MSCs Are Dynamic, Fate-Restricted Participants in Bone Maintenance and RegenerationCell Stem Cell, 2012
- Regulation of gene expression and subcellular protein distribution in MLO-Y4 osteocytic cells by lysophosphatidic acid: Relevance to dendrite outgrowthBone, 2011
- Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesisBiomaterials, 2010
- Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevanceProstaglandins & Other Lipid Mediators, 2010
- Lysophosphatidic acid-induced arterial wall remodeling: Requirement of PPARγ but not LPA1 or LPA2 GPCRCellular Signalling, 2009
- Sphingosine 1-phosphate chemical biologyBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- Sustained release of sphingosine 1-phosphate for therapeutic arteriogenesis and bone tissue engineeringBiomaterials, 2008
- Lysophosphatidic acid (LPA) and angiogenesisAngiogenesis, 2008
- Delivery of Sphingosine 1-Phosphate from Poly(ethylene glycol) HydrogelsBiomacromolecules, 2006